Clinical Trials Directory

Trials / Completed

CompletedNCT05359094

Probiotic Supplements in Chronic Kidney Disease

To Explore the Effect of Probiotic Supplements in Chronic Kidney Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Taichung Veterans General Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

This research will investigate the effect of oral probiotic supplements on renal function, uremic toxins inflammatory response, nutrition status, gastrointestinal symptoms, and QoL with Chronic kidney disease.

Detailed description

Chronic kidney disease (CKD) with gut microbiota was different from a normal person. Some gut microbiota produces short-chain fatty acids or induces functional enzymes beneficial to patients. On the other hand, some gut microbiota may also metabolize amino acids into p-cresol and indole which were leading to the accumulation of urinary toxins and damage to the kidney. This research will investigate the effect of oral probiotic supplements on renal function, uremic toxins, inflammatory response, nutrition status, gastrointestinal symptoms, and QoL with CKD.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlaceboPlacebo (Microcrystalline α-cellulose) supplement with a Plant-Dominant Low-Protein Diet
DIETARY_SUPPLEMENTProbioticsProbiotics(Pediococcus acidilactici GKA4) supplement with a Plant-Dominant Low-Protein Diet

Timeline

Start date
2022-06-01
Primary completion
2023-08-08
Completion
2024-07-15
First posted
2022-05-03
Last updated
2024-07-23

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05359094. Inclusion in this directory is not an endorsement.